
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/enfamil-and-smaller-baby-formula-brands-test-dominance-of-abbotts-similac-11655026203
Listen to article
(2 minutes)
Baby-formula makers have their best shot in decades to shake up a U.S. market long dominated by two players.
Long-established companies and startups are angling to emerge from a nationwide formula shortage in a stronger market position as they work to hold on to new customers who are more willing to switch brands while shelves remain thinly stocked.
Continue reading your article witha WSJ membership
WSJ Membership
Customer Service
Tools & Features
Ads
More
Dow Jones Products
WSJ Membership
Customer Service
Tools & Features
Ads
More
Copyright Â©2022 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

